[Connecting markets on both sides of the Kármán Line]
Xponential Space is a strategic advisory and commercialization firm with a global presence, accelerating the adoption of space-enabled solutions across industries back on Earth.
We bridge the gap between established terrestrial markets and the rapidly evolving space economy, helping organizations translate advances in the space sector into tangible commercial value.
By identifying where space capabilities can solve real business challenges, we enable organizations to drive innovation, unlock new growth opportunities, and build lasting competitive advantage.
We envision a future where space is no longer viewed as a niche sector, but as a foundational enabler of innovation across the global economy. From life sciences and advanced materials to next-generation manufacturing, the unique capabilities of space will unlock breakthroughs that reshape industries, create new markets, and improve lives on Earth.
As access to orbit expands and in-space infrastructure matures, space will become a critical component of the global industrial value chain. Organizations across every sector will increasingly leverage space to accelerate innovation, develop next-generation products, strengthen supply chains, and create lasting competitive advantage.
Realizing this future requires more than technological progress. It demands a market-driven approach that aligns space capabilities with real-world industry challenges and commercial opportunities. The next phase of the space economy will not be defined solely by advances in launch systems, satellites, or orbital infrastructure, but by the successful integration of space into the world’s largest industries.
At Xponential Space, we are committed to accelerating this transformation by helping organizations identify, evaluate, and commercialize the opportunities emerging from the space economy.
— Ignacio Krasovitzky, CEO, Xponential Space
Meet the Experts Shaping the Future of the Space Economy
Ignacio is an entrepreneur, strategist, and commercialization advisor focused on unlocking the economic potential of the emerging space economy. With more than three decades of experience spanning consulting, investment, and market intelligence, he has advised global organizations across life sciences, technology, and industrial sectors on growth, innovation, and strategic transformation.
At Xponential Space, Ignacio works at the intersection of space and industry, helping companies, investors, and institutions identify, develop, and commercialize opportunities enabled by next-generation space capabilities.
His perspective is shaped by deep engagement across the global space ecosystem, including executive programs at the International Space University and Massachusetts Institute of Technology, as well as advisory roles supporting startups and emerging space ventures.
Ecem leads strategic partnerships, commercial growth, and business development initiatives at Xponential Space, helping connect space-enabled technologies with the life sciences and biotechnology sectors. With over 10 years of international experience across biotechnology, pharmaceuticals, medical devices, and emerging space biotech, she specializes in translating scientific innovation into commercial opportunities through global market expansion, strategic collaborations, and customer engagement.
Combining a strong scientific background in bioengineering and regenerative medicine with extensive international commercial experience, Ecem works to accelerate the adoption and commercialization of next-generation life sciences technologies, both on Earth and in space.
Peter leads Xponential Space’s activities across Central and Eastern Europe, driving the company’s regional growth through strategic partnerships and ecosystem development.
He plays a key role in expanding the company’s footprint across Central and Eastern Europe, enabling organizations to access and capitalize on the growing space economy.
A multiple award-winning space professional, innovation expert, and entrepreneur, Peter brings experience across venture capital, technology commercialization, and innovation ecosystems. His background spans both industry and academia, with leadership roles across the Central and Eastern European space landscape, including initiatives such as the Óbuda University Space Lab and broader regional space programs.
As Regional Lead for India, Ritesh drives regional growth, strategic partnerships, and ecosystem engagement across one of the world’s fastest-growing and most important space markets. He works closely with industry stakeholders, institutions, and partners to identify high-impact opportunities and strengthen collaboration across the evolving space economy.
With a strong understanding of India’s innovation landscape and the broader global space industry, Ritesh brings a unique ability to connect regional opportunities with international capabilities and strategic relationships.
Ritesh has contributed to initiatives with the European Space Agency and brings experience spanning business development, partnerships, and go-to-market strategy at the intersection of emerging technologies and commercialization.
Tania Robles brings experience across the space sector spanning strategy, program management, ecosystem development, and space education. Through her work with the Mexican Space Agency and the International Space University, she has contributed to initiatives centered on collaboration, knowledge exchange, and community building across the global space ecosystem.
At Xponential Space, Tania supports the development of knowledge-driven initiatives designed to increase awareness and understanding of emerging opportunities across the space economy.
Hamid Soorghali is an industrial and technology strategist and the Founder & CEO of Elethron, a UK-based deeptech company developing microgravity process-engineering systems and platform solutions to advance novel materials and chemistries for semiconductor, photonic, and quantum technologies.
He has more than a decade of experience across advanced materials, high-value manufacturing, and the space industry, working across corporate strategy, innovation, investment, and commercialisation.
Before founding Elethron, Hamid worked in boutique growth strategy and M&A advisory, including at Future Materials Group, where he advised advanced materials and specialty chemicals companies across aerospace, critical infrastructure, high-value manufacturing, and advanced optoelectronics.
He later joined the Satellite Applications Catapult, contributing to the UK and European space innovation ecosystem. There, he led strategic initiatives focused on techno-economic assessments for infrastructure investment, commercialisation strategy, and market development, with a particular focus on emerging in-orbit infrastructure. This included leading the development of the European Space Agency-backed Advanced Materials and In-Orbit Manufacturing Accelerator.
Hamid holds an MA in Political Science from SOAS University of London and received the Ken Robertson Prize from Aberystwyth University’s Centre for International Security.
Davide Marotta, Ph.D. is a scientist, inventor, and leader in space biomanufacturing and microgravity-enabled life sciences. Born and raised in Palermo, Italy, and based in the United States, his work sits at the intersection of regenerative medicine, advanced biomaterials, and the emerging in-space manufacturing economy.
Davide Marotta is a scientist, inventor, and internationally recognized leader in space biomanufacturing and microgravity-enabled life sciences. His work focuses on advancing regenerative medicine, advanced biomaterials, and the commercialization of in-space manufacturing.
He currently serves as Chief Scientific Officer at Helogen Corporation, Founder of the International Society for Space Manufacturing (ISSM), Honorary Professor at the University of Technology Sydney, and Board Member of the American Society for Gravitational and Space Research (ASGSR). Through ISSM, he is helping build a global ecosystem that connects academia, industry, government, and commercial space organizations to accelerate the development of the in-space manufacturing economy.
Previously, Davide served as Program Director for In-Space Biomanufacturing at the ISS National Laboratory, where he helped establish biomanufacturing as a strategic pillar of the commercial space economy, leading programs spanning regenerative medicine, stem cells, organoids, biomaterials, and advanced biofabrication. Earlier, he was a scientist at the New York Stem Cell Foundation, conducting pioneering research on brain organoids, neurodegenerative disease models, and the application of microgravity to therapeutic discovery.
With a multidisciplinary background spanning molecular biology, regenerative medicine, and commercial space, Davide is recognized as one of the leading experts driving the translation of microgravity-enabled life sciences into commercially viable healthcare and manufacturing applications.
Paul Reichert is a seasoned pharmaceutical executive with more than 30 years of experience spanning drug discovery and, commercialization. He has successfully bridged scientific innovation with commercial strategy, helping organizations translate emerging technologies into high-value healthcare solutions.
During his career at Merck & Co., Paul led pioneering research into the application of microgravity to pharmaceutical development, serving as Principal Investigator for the company’s International Space Station missions focused on the crystallization and formulation of pembrolizumab (Keytruda®). His work demonstrated how microgravity can improve the formulation of complex biologics and helped establish the commercial potential of space-enabled pharmaceutical R&D.
Paul has since advised pharmaceutical companies, biotechnology firms, research institutions, and commercial space organizations on market strategy, commercialization pathways, partnership development, and customer engagement. His unique combination of pharmaceutical expertise, commercial leadership, and firsthand experience developing one of the industry’s most recognized space-enabled drug research programs positions him as a leading expert at the intersection of life sciences and the emerging space economy.
Guillermo Söhnlein is a serial entrepreneur, investor, and exploration leader with more than 25 years of experience building ventures across the space, ocean, and frontier technology sectors.
He currently serves as Co-Founder and Chairman of the Humans2Venus Foundation, Co-Founder and CEO of Blue Marble Exploration, and Co-Founder and Chief Strategy Officer of Space Bridge Partners, where he focuses on connecting commercial space ventures with private capital and strategic partnerships. He also advises several space-focused venture capital firms and emerging technology companies.
Guillermo founded Space Angels Network, one of the first investment platforms dedicated to commercial space startups, and co-founded OceanGate, helping pioneer privately operated crewed deep-ocean exploration.
An elected member of The Explorers Club, Guillermo combines entrepreneurship, investment, and expedition leadership to advance the commercialization of frontier technologies and expand humanity’s presence across both Earth and space.
Don’t see a role that fits your background? We’re growing fast and always looking for exceptional talents. Share your interest with us and stay in our radar as we grow.
Submit your interestMarket Development Lead
Apply nowAdvanced Materials & Space Manufacturing Director
Apply nowCommercial Strategy Director
Apply nowMarket Intelligence (Space Economy) Director
Apply nowBusiness Development & Strategic Partnerships Market Development Lead
Apply nowLife Sciences & Microgravity Applications Market Analyst (Senior) / Associate
Apply nowLife Sciences & Microgravity Applications Market Analyst (Junior) / Associate
Apply now